RT Conference Proceedings
T1 Final efficacy results from IMpower132: First-line atezolizumab plus chemotherapy in patients with stage IV non-squamous NSCLC
A1 Nishio, M.
A1 Barlesi, F.
A1 Ball, S.
A1 Bordoni, R.
A1 Cobo, M.
A1 Dubray-Longeras, P.
A1 Goldschmidt, J.
A1 Novello, S.
A1 Orlandi, F. J.
A1 Sanborn, R.
A1 Szalai, Z.
A1 Ursol, G.
A1 Mendus, D.
A1 Wang, L.
A1 Wen, X.
A1 McCleland, M.
A1 Hoang, T.
A1 Phan, S.
A1 Socinski, M.
PB Elsevier
SN 0923-7534
YR 2020
FD 2020-11-01
LK https://hdl.handle.net/10668/24446
UL https://hdl.handle.net/10668/24446
LA en
DS RISalud
RD Apr 6, 2025